2085-0032 Screening compound: 4-phenyl-2-(piperidin-1-yl)quinazoline

2085-0032 Screening compound: 4-phenyl-2-(piperidin-1-yl)quinazoline
2085-0032 Screening compound: 4-phenyl-2-(piperidin-1-yl)quinazoline alternative view

Chemical Structure Depiction of ChemDiv screening compound 2085-0032
4-phenyl-2-(piperidin-1-yl)quinazoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2085-0032

Molecular Formula

C19H19N3 (C19 H19 N3)

Compound Name

4-phenyl-2-(piperidin-1-yl)quinazoline

IUPAC name

4-phenyl-2-(piperidin-1-yl)quinazoline

SMILES

C(CC1)CCN1c1nc2ccccc2c(-c2ccccc2)n1

InChI

InChI=1S/C19H19N3/c1-3-9-15(10-4-1)18-16-11-5-6-12-17(16)20-19(21-18)22-13-7-2-8-14-22/h1,3-6,9-12H,2,7-8,13-14H2

InChI Key

OLRQEYHHPDXGTO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01152744

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

289.38

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

4.850

Distribution Coefficient, logD

4.850

Water Solubility, LogSw

-4.99

Polar Surface Area

21.403

Acid Dissociation Constant (pKa)

20.54

Base Dissociation Constant (pKb)

4.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

2085-0032 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with 2085-0032 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2085-0032?
Check Price and Availability of 2085-0032, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2085-0032 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2085-0032
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2085-0032
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2085-0032 available by request